The Korean Journal of Nuclear Medicine Technology (핵의학기술)
- Volume 14 Issue 2
- /
- Pages.186-189
- /
- 2010
- /
- 1229-9901(pISSN)
- /
- 2982-8406(eISSN)
Changes in Figures of FSH and E2 while Breast Cancer Patients Treated with Surgery takes Tamoxifen
유방암 수술환자가 Tamoxifen복용기간 중 발생하는 FSH와 E2의 수치 변화
- Kwon, Won-Hyun (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
- Moon, Ki-Choon (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
- Kim, Hye-Sook (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
- Lee, In-Won (Department of Nuclear Medicine, Seoul National University Bundang Hospital) ;
- Shin, Suk-Hee
- Received : 2010.08.30
- Accepted : 2010.09.13
- Published : 2010.10.30
Abstract
Purpose: As many patients often showed the value of menopause although they were women of childbearing age, this study looked into their previous history. According to the findings, they were patients with a mastectomy due to breast cancer and were taking breast cancer treatment Tamoxifen (the women hormone inhibitor) after chemotherapy. This study is conducted to examine changes in FSH and E2 concentration of patients breast cancer patients of childbearing age according to Tamoxifen used to prevent recurrence of breast cancer and proliferation of mammary parenchyma. Materials and Methods: This study aims to investigate similarity in patients treated with surgery who were in their childbearing age and in values of FSH and E2 by dividing test results of FSH and E2 requested at the department of nuclear medicine among patients who visited this hospital from Jan. 2009 to Mar. 2010 into women of childbearing age (n=50), menopausal women (n=50), and patients with breast cancer surgery who take Tamoxifen (n=50) and then comparing the test results. Results: The FSH and E2 test results of 50 patients were compared and analyzed as average